Showing results (31-40 of 236) with videos related to
Sort By:
Pageof 24
The American Journal of Cardiology|March 16, 2001
Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (The OPTIMAAL Trial). OPTIMAAL Trial Steering Committee and Investigators. Optimal Trial in Myocardial Infarction with the Angiotensin II Antagonist LosartanK Dickstein, J Kjekshus, The American Journal of Cardiology|July 11, 1988
Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)K Swedberg, J KjekshusUgeskrift for Laeger|June 11, 1990
[Occurrence of cardiovascular risk factors among working Danish men 20-59 years of age]L U Gerdes, A M Bak, O FaergemanThe American Journal of Cardiology|July 11, 1988
Tolerability of enalapril in congestive heart failureJ Kjekshus, K SwedbergScandinavian Journal of Clinical and Laboratory Investigation|May 1, 1981
The magnitude of metabolically induced changes in the density of human low-density lipoproteinsP Weech, G Mills, H Meinertz, et al.European Journal of Clinical Pharmacology|January 1, 1991
Comparison of the effects of xamoterol, atenolol and propranolol on breathlessness, fatigue and plasma electrolytes during exercise in healthy volunteersE V Sørensen, H K Jensen, O FaergemanBritish Heart Journal|November 1, 1989
Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricleE Vigholt-Sørensen, O Faergeman, H M SnowThe American Journal of Cardiology|March 12, 1999
Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist LosartanK Dickstein, J KjekshusDiabetes Care|May 1, 1983
Timolol treatment after myocardial infarction in diabetic patientsT Gundersen, J KjekshusUgeskrift for Laeger|June 11, 1990
[Measurement of cholesterol in capillary blood using the Reflotron system. Results from approximately 1,000 comparisons with reference measurements of cholesterol in venous serum]L U Gerdes, A M Bak, O FaergemanPageof 24